Principal Executive Officer · Myovant Sciences Ltd. (MYOV)

David Marek

A named executive officer of Myovant Sciences in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$6,247,509

Salary $750,000Stock awards $2,410,027

FY2020: $10,276,517

1st of 4 named executive officers at Myovant Sciences by FY2021 total.

4 named officers on file for Myovant Sciences, FY2021

David Marek’s pay file — $29

  • 2 fiscal years of pay, line by line
  • MYOV’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Myovant Sciences’s whole pay program stands against its peers

  • Myovant Sciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MYOV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed July 28, 2022 (DEF 14A).

Free

Get David Marek’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Marek compensation by year

Myovant Sciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Myovant Sciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$150,544$750,000
Bonus$1,000,000$0
Stock awards$4,581,981$2,410,027
Option awards$4,383,438$2,407,333
Non-equity incentive$116,000$473,000
Pension and deferred compensation$0$0
All other$44,554$207,149
Total$10,276,517$6,247,509

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Myovant Sciences Ltd. DEF 14A filed July 28, 2022, accession 0001140361-22-027161, and prior-year filings.

How this page was built: the Myovant Sciences Ltd. filed document, accession 0001140361-22-027161. Every figure is read from that document and cited to the page and table it appears in. Filed July 28, 2022.

$10.3M
$6.2M
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU167,307$2,228,529—
RSU134,789$1,795,389—
Option229,821—$20.54
Option208,218—$17.88

Per the Outstanding Equity Awards at Fiscal Year-End table in Myovant Sciences Ltd.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Myovant Sciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
David Marek · this pagePrincipal Executive Officer$6,247,509
Uneek MehraPrincipal Financial Officer$5,164,872
Frank KarbeFormer Principal Financial and Accounting Officer$4,451,137
Lauren MerendinoChief Commercial Officer$3,463,677

Board service

Myovant Sciences board · FY2022

How this board is paid

Company policy: Myovant Sciences pays directors a $50,000 cash retainer and $266,200 in Options. As stated in Myovant Sciences's FY2022 proxy.

The full Myovant Sciences compensation record

free company brief

This page is one person within Myovant Sciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Myovant Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Marek's compensation dossier · One-time report. No refunds.